The dysregulation of the immune system that triggers these pathological mechanisms in the progression of MS includes chronic and elevated levels of pro-inflammatory cytokines (interleukin-1β, interleukin-6, tumor necrosis factor-alpha, interleukin-17, and tumor necrosis factor-alpha), chemokines, and autoantibodies (41). Here, TNF is linked to myeloid sarcoma.